ZOJWALLA NASEEM (CHIEF MEDICAL OFFICER) sold 19.4% of their position (27.80K shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $250.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/11/2024ACC: 0001415889-24-029026
Officer· CHIEF MEDICAL OFFICER
Since Jan 2022
+24.20K
Net shares
Net buyer
$250.5K
Total sold
3
Open market trades
0B · 3S
4
Total transactions
52K acquired · 27.80K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+52K
Price / share
—
Trade value
—
% of position
56.9%
12/9/2024
91.31K→143.31K
Common Stock
Direct
Shares
−13.28K
Price / share
$9.37
Trade value
$124.46K
% of position
9.3%
12/10/2024
143.31K→130.03K
Common Stock
Direct
Shares
−14.20K
Price / share
$8.66
Trade value
$122.99K
% of position
10.9%
12/11/2024
130.03K→115.83K
Common Stock
Direct
Shares
−320.00
Price / share
$9.39
Trade value
$3K
% of position
0.3%
12/11/2024
115.83K→115.51K
Total
Net shares
+24.20K
Net value
-$250.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2024 | A · Award | +52K | — | — | 56.9% | 91.31K | 143.31K |
| Common Stock Direct | 12/10/2024 | S · Sale | −13.28K | $9.37 | $124.46K | 9.3% | 143.31K | 130.03K |
| Common Stock Direct | 12/11/2024 | S · Sale | −14.20K | $8.66 | $122.99K | 10.9% | 130.03K | 115.83K |
| Common Stock Direct | 12/11/2024 | S · Sale | −320.00 | $9.39 | $3K | 0.3% | 115.83K | 115.51K |
| Total | +24.20K | -$250.46K | ||||||
Derivative Transactions0
No derivative transactions reported